Saol Therapeutics Inc.

GA · United States · Reporting entity ID 100000151581

Total reported 2019–2025

$405K

#1,669 of 2,960 reporting companies — 0% of all reported industry payments

$255K in general payments across 1,452 records, plus $149K in research funding across 3 records.

How it breaks down

General payments $255,230

Research funding $149,448

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.